Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM4 | P08173 | 1/20 | 0.44 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 2/20 | 0.38 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.38 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4161374 | 1.00 | CHRM4 (0.44) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 | |
| SCHEMBL5385059 | 0.99 | CHRM4 (0.43) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 | |
| SCHEMBL4889902 | 0.82 | ALDH1A1 (0.34) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 | |
| SCHEMBL4184504 | 0.82 | OPRM1 (0.33) | — | |
| SCHEMBL5116054 | 0.82 | BCHE (0.47) | ALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL5115684 | 0.81 | ALDH1A1 (0.50) | ALDH1A1L3MBTL1 | |
| SCHEMBL23358779 | 0.80 | CHRM3 (0.41) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 | |
| SCHEMBL20476348 | 0.79 | KDM4E (0.41) | CHRM3ALDH1A1CYP2D6 | |
| SCHEMBL5473748 | 0.79 | CHRM3 (0.42) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 | |
| SCHEMBL1707214 | 0.79 | CHRM3 (0.42) | CHRM4CHRM5CHRM1CHRM3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2580194-A1 | PROCESS FOR THE PREPARATION OF GLYCOPYRRONIUM CHLORIDE | Chiesi Farmaceutici S.p.A. (IT) | 2013-04-17 | — | — | EP | claimed |
| WO-2011157536-A1 | PROCESS FOR THE PREPARATION OF GLYCOPYRRONIUM CHLORIDE | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-12-22 | — | — | WO | claimed |
| US-20110306650-A1 | PROCESS FOR THE PREPARATION OF GLYCOPYRRONIUM CHLORIDE | CHIESI FARMACEUTICI S.P.A. (IT) | 2011-12-15 | — | — | US | claimed |
| US-7253182-B2 | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments | SOFOTEC GMBH & CO. KG (DE) | 2007-08-07 | — | — | US | disclosed |
| US-6613795-B2 | Respiratory system disorders; muscle relaxants | Noe, Christian (DE) | 2003-09-02 | — | — | US | disclosed |
| US-20020173536-A1 | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments | CHRISTIAN NOE AND ERNST MUTSCHLER | 2002-11-21 | — | — | US | disclosed |
| US-6307060-B1 | ANTISPASMODIC AGENTS | Noe, Christian | 2001-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173536-A1 | Enantiomerically pure basic arylcycloalkylhydroxycarboxylic esters, processes for their preparation and their use in medicaments | CYP2A13, CYP3A43, HCAR2 | CHRM4 1498/4885CHRM5 1225/4885CHRM1 1273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.